97
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Discovery of Alpha-Tocopheryl Succinate as a Cancer Treatment Agent Led to the Development of Methods to Potentially Improve the Efficacy of Cancer Therapy

Pages 776-782 | Received 03 Nov 2022, Accepted 28 Jan 2023, Published online: 03 Feb 2023

References

  • Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res. 1979;39(3):663–81.
  • Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976;73(10):3685–9. doi:10.1073/pnas.73.10.3685.
  • Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 1979;301(13):687–90. doi:10.1056/NEJM197909273011303.
  • Prasad KN, Hsie AW. Morphologic differentiation of mouse neuroblastoma cells induced in vitro by dibutyryl adenosine 3':5'-cyclic monophosphate. Nat New Biol. 1971;233(39):141–2. doi:10.1038/newbio233141a0.
  • Prasad KN, Sinha PK, Ramanujam M, Sakamoto A. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci U S A. 1979;76(2):829–32. doi:10.1073/pnas.76.2.829.
  • Prasad KN, Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res. 1982;42(2):550–5.
  • Kline K, Cochran GS, Sanders BG. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr Cancer. 1990;14(1):27–41. doi:10.1080/01635589009514075.
  • Prasad KN, Kumar R. Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture. Nutr Cancer. 1996;26(1):11–9. doi:10.1080/01635589609514458.
  • Rama BN, Prasad KN. Study on the specificity of alpha-tocopheryl (vitamin E) acid succinate effects on melanoma, glioma and neuroblastoma cells in culture. Proc Soc Exp Biol Med. 1983;174(2):302–7. doi:10.3181/00379727-174-41741.
  • Ripoll EA, Rama BN, Webber MM. Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro. J Urol. 1986;136(2):529–31. doi:10.1016/s0022-5347(17)44937-8.
  • Israel K, Yu W, Sanders BG, Kline K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer. 2000;36(1):90–100. doi:10.1207/S15327914NC3601_13.
  • Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci U S A. 2002;99(11):7408–13. doi:10.1073/pnas.102014399.
  • Yu A, Somasundar P, Balsubramaniam A, Rose AT, Vona-Davis L, McFadden DW. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. J Surg Res. 2002;105(1):65–8. doi:10.1006/jsre.2002.6454.
  • Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC, 3rd, Birchenall-Roberts MC. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res. 1997;57(5):881–90.
  • Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 1999;59(4):953–61.
  • Pussinen PJ, Lindner H, Glatter O, Reicher H, Kostner GM, Wintersperger A, Malle E, Sattler W. Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochim Biophys Acta. 2000;1485(2-3):129–44. doi:10.1016/S1388-1981(00)00035-4.
  • Prasad KN, Kumar B, Yan XD, Hanson AJ, Cole WC. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J Am Coll Nutr. 2003;22(2):108–17. doi:10.1080/07315724.2003.10719283.
  • Huang PH, Wang D, Chuang HC, Wei S, Kulp SK, Chen CS. alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis. Carcinogenesis. 2009;30(7):1125–31. doi:10.1093/carcin/bgp112.
  • Kaczor T. Alpha-tocopheryl succinate in cancer care. Nat Med J. 2014. https://www.naturalmedicinejournal.com/journal/alpha-tocopheryl-succinate-cancer-care
  • Gu X, Schwartz JL, Pang X, Zhou Y, Sirois DA, Sridhar R. Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture. Cancer Lett. 2006;239(2):281–91. doi:10.1016/j.canlet.2005.08.028.
  • Cohrs RJ, Torelli S, Prasad KN, Edwards-Prasad J, Sharma OK. Effect of vitamin E succinate and a cAMP-stimulating agent on the expression of c-myc and N-myc and H-ras in murine neuroblastoma cells. Int J Dev Neurosci. 1991;9(2):187–94. doi:10.1016/0736-5748(91)90011-A.
  • Wei CW, Yu YL, Lu JY, Hung YT, Liu HC, Yiang GT. Anti-cancer effects of sulfasalazine and vitamin E succinate in MDA-MB 231 triple-negative breast cancer cells. Int J Med Sci. 2019;16(4):494–500. doi:10.7150/ijms.30380.
  • Neuzil J, Svensson I, Weber T, Weber C, Brunk UT. alpha-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS letters. 1999;445(2-3):295–300. doi:10.1016/S0014-5793(99)00141-6.
  • Neuzil J, Swettenham E, Wang XF, Dong LF, Stapelberg M. alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling. FEBS Lett. 2007;581(24):4611–5. doi:10.1016/j.febslet.2007.08.051.
  • dos Santos GAS, Abreu e Lima RS, Pestana CR, Lima ASG, Scheucher PS, Thomé CH, Gimenes-Teixeira HL, Santana-Lemos BAA, Lucena-Araujo AR, Rodrigues FP, et al. (+)alpha-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo. Leukemia. 2012;26(3):451–60. doi:10.1038/leu.2011.216.
  • Lee E, Choi M-K, Lee Y-J, Ku J-L, Kim K-H, Choi J-S, Lim S-J. Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells. Carcinogenesis. 2006;27(11):2308–15. doi:10.1093/carcin/bgl073.
  • Patacsil D, Osaiyi S, Tran AH, et al. Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. Fron Neurosci. 2022;16:890021.
  • Lim SJ, Choi MK, Kim MJ, Kim JK. Alpha-tocopheryl succinate potentiates the paclitaxel-induced apoptosis through enforced caspase 8 activation in human H460 lung cancer cells. Exp Mol Med. 2009;41(10):737–45. doi:10.3858/emm.2009.41.10.080.
  • Li CW, Lai YJ, Hsu JL, Hung MC. Activation of phagocytosis by immune checkpoint blockade. Front Med. 2018;12(4):473–80. doi:10.1007/s11684-018-0657-5.
  • Huang X, Neckenig M, Sun J, Jia D, Dou Y, Ai D, Nan Z, Qu X. Vitamin E succinate exerts anti-tumour effects on human cervical cancer cells via the CD47-SIRPa pathway both in vivo and in vitro. J Cancer. 2021;12(13):3877–86. doi:10.7150/jca.52315.
  • Sahu SN, Edwards-Prasad J, Prasad KN. Effect of alpha tocopheryl succinate on adenylate cyclase activity in murine neuroblastoma cells in culture. J Am Coll Nutr. 1988;7(4):285–93. doi:10.1080/07315724.1988.10720245.
  • Jha MN, Bedford JS, Cole WC, Edward-Prasad J, Prasad KN. Vitamin E (d-alpha-tocopheryl succinate) decreases mitotic accumulation in gamma-irradiated human tumor, but not in normal, cells. Nutrition and Cancer. 1999;35(2):189–94. doi:10.1207/S15327914NC352_14.
  • Kumar B, Jha MN, Cole WC, Bedford JS, Prasad KN. D-alpha tocopheryl succinate (vitamin E) enhances radiation-induced chromosomal damage levels in human cancer cells, but reduced it in normal cells. J Am Coll Nutr. 2002;21(4):339–43. doi:10.1080/07315724.2002.10719232.
  • Sarria A, Prasad KN. dl-alpha-Tocopheryl succinate enhances the effect of gamma-irradiation on neuroblastoma cells in culture. Proc Soc Exp Biol Med. 1984;175(1):88–92. doi:10.3181/00379727-175-41772.
  • Singh PK, Wise SY, Ducey EJ, Fatanmi OO, Elliott TB, Singh VK. alpha-Tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res. 2012;177(2):133–45. doi:10.1667/rr2627.1.
  • Wei CW, Yu YL, Chen YH, Hung YT, Yiang GT. Anticancer effects of methotrexate in combination with alphatocopherol and alphatocopherol succinate on triplenegative breast cancer. Oncol Rep. 2019;41(3):2060–6. doi:10.3892/or.2019.6958.
  • Kulikov AV, Vdovin AS, Zhivotovsky B, Gogvadze V. Targeting mitochondria by alpha-tocopheryl succinate overcomes hypoxia-mediated tumor cell resistance to treatment. Cell Mol Life Sci. 2014;71(12):2325–33. doi:10.1007/s00018-013-1489-8.
  • Ivanova D, Zhelev Z, Zlateva G, Lazarova D, Yaneva Z, Panovska R, Aoki I, Bakalova R. Effect of alpha-tocopheryl succinate on the cytotoxicity of anticancer drugs towards leukemia lymphocytes. Anticancer Res. 2022;42(1):547–54. doi:10.21873/anticanres.15512.
  • Rama BN, Prasad KN. Effect of hyperthermia in combination with vitamin E and cyclic AMP on neuroblastoma cells in culture. Life Sci. 1984;34(21):2089–97. doi:10.1016/0024-3205(84)90374-6.
  • Prasad KN. Butyric acid: a small fatty acid with diverse biological functions. Life Sci. 1980;27(15):1351–8. doi:10.1016/0024-3205(80)90397-5.
  • Rama BN, Prasad KN. Effects of dl-alpha-tocopheryl succinate in combination with sodium butyrate and cAMP stimulating agent on neuroblastoma cells in culture. Int J Cancer. 1984;34(6):863–7. doi:10.1002/ijc.2910340619.
  • Helson L, Verma M, Helson C. Vitamin E and human neuroblastoma. In Meysluns F, Prasad KN, editors. Modulation and mediation of cancer by vitamins. Karger: Basal; 1983. p. 258–65.
  • Shklar G, Schwartz J, Trickler DP, Niukian K. Regression by vitamin E of experimental oral cancer. J Natl Cancer Inst. 1987;78(5):987–92.
  • Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res. 2000;93(1):163–70. doi:10.1006/jsre.2000.5948.
  • Malafa MP, Fokum FD, Mowlavi A, Abusief M, King M. Vitamin E inhibits melanoma growth in mice. Surgery. 2002;131(1):85–91. doi:10.1067/msy.2002.119191.
  • Barnett KT, Fokum FD, Malafa MP. Vitamin E succinate inhibits colon cancer liver metastases. J Surg Res. 2002;106(2):292–8. doi:10.1006/jsre.2002.6466.
  • Neuzil J, Weber T, Schröder A, Lu M, Ostermann G, Gellert N, Mayne GC, Olejnicka B, Nègre-Salvayre A, Stícha M, et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. Faseb J. 2001;15(2):403–15. doi:10.1096/fj.00-0251com.
  • Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002;8(3):863–9.
  • Wang J, Ma W, Guo Q, Li Y, Hu Z, Zhu Z, Wang X, Zhao Y, Chai X, Tu P, et al. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. Int J Nanomedicine. 2016;11:5851–70. doi:10.2147/IJN.S113882.
  • Mei H, Li J, Cai S, Zhang X, Shi W, Zhu H, Cao J, He B. Mitochondria-acting carrier-free nanoplatform self-assembled by alpha-tocopheryl succinate carrying cisplatin for combinational tumor therapy. Regen Biomater. 2021;8(4):rbab029.
  • Riestra-Ayora J, Sánchez-Rodríguez C, Palao-Suay R, Yanes-Díaz J, Martín-Hita A, Aguilar MR, Sanz-Fernández R. Paclitaxel-loaded polymeric nanoparticles based on alpha-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: in vivo murine model. Drug Deliv. 2021;28(1):1376–88. doi:10.1080/10717544.2021.1923863.
  • Song M, Wang J, Lei J, Peng G, Zhang W, Zhang Y, Yin M, Li J, Liu Y, Wei X, et al. Preparation and evaluation of liposomes co-loaded with doxorubicin, phospholipase D inhibitor 5-fluoro-2-indolyl deschlorohalopemide (FIPI) and D-alpha tocopheryl acid succinate (alpha-TOS) for anti-metastasis. Nanoscale Res Lett. 2019;14(1):138. doi:10.1186/s11671-019-2964-4.
  • Tomasetti M, Rippo MR, Alleva R, Moretti S, Andera L, Neuzil J, Procopio A. Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant ­mesothelioma cells. Br J Cancer. 2004;90(8):1644–53. doi:10.1038/sj.bjc.6601707.
  • Dalen H, Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation. Br J Cancer. 2003;88(1):153–8. doi:10.1038/sj.bjc.6600683.
  • Tomasetti M, Nocchi L, Neuzil J, Goodwin J, Nguyen M, Dong L, Manzella N, Staffolani S, Milanese C, Garrone B, et al. Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death. PLoS One. 2012;7(12):e52263. doi:10.1371/journal.pone.0052263.
  • Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer. 1994;22(3):233–45. doi:10.1080/01635589409514349.
  • Tam K-W, Ho C-T, Tu S-H, Lee W-J, Huang C-S, Chen C-S, Wu C-H, Lee C-H, Ho Y-S. alpha-Tocopherol succinate enhances pterostilbene anti-tumor activity in human breast cancer cells in vivo and in vitro. Oncotarget. 2018;9(4):4593–606. doi:10.18632/oncotarget.23390.
  • Kovarova J, Bajzikova M, Vondrusova M, Stursa J, Goodwin J, Nguyen M, Zobalova R, Pesdar EA, Truksa J, Tomasetti M, et al. Mitochondrial targeting of alpha-tocopheryl succinate enhances its anti-mesothelioma efficacy. Redox Rep. 2014;19(1):16–25. doi:10.1179/1351000213Y.0000000064.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.